Life Healthcare Group Holdings Ltd
SWB:L53
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Life Healthcare Group Holdings Ltd
SWB:L53
|
ZA |
|
Regeneron Pharmaceuticals Inc
LSE:0R2M
|
US |
Wall St Price Targets
L53 Price Targets Summary
Life Healthcare Group Holdings Ltd
According to Wall Street analysts, the average 1-year price target for L53 is 0.645 EUR with a low forecast of 0.57 EUR and a high forecast of 0.711 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is L53's stock price target?
Price Target
0.645
EUR
According to Wall Street analysts, the average 1-year price target for L53 is 0.645 EUR with a low forecast of 0.57 EUR and a high forecast of 0.711 EUR.
What is the Revenue forecast for Life Healthcare Group Holdings Ltd?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 6%.
What is the Gross Profit forecast for Life Healthcare Group Holdings Ltd?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 3 years is 7%.
What is the Net Income forecast for Life Healthcare Group Holdings Ltd?
Projected CAGR
-15%
Over the last 14 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 3 years is -15%.
